Biocept Important In The Fight Against Breast Cancer: Is 2021 An Essential Year?
BIOC

Biocept Inc. ($BIOC) recently released its third-quarter results, which showed that revenue had quadrupled year-over-year (revenues of $6.6 million). This was explained by analysts on the basis of a strategically strong move by offering a molecular diagnostics to test the coronavirus (RT-PCR test). Offering COVID-19 testing services has been the right choice and is expected…

Is Milestone Scientific MLSS NYSE A Buy ! Dental Product Sales Rose Nearly 700% – Watch For Breakout When Closing Above $1.65
MLSS

These shares have consolidated recently and have attempted to breakout above the $1.65 level .Consensus Target Price remains $4.00 and rated as a BUY . A seven fold increase in dental sales Q3 over Q2 2020 we believe will drive these shares  significantly higher in the coming months . Two Wall Street analysts have issued ratings…

Moderna popular in Europe: vaccine is 94.5% effective while continent is gasping for breath
MRNA

Milestone Scientific MLSS NYSE – Q3 VS Q2 Up Seven Fold Dental Services Watch For Breakout It is not entirely unexpected that the pharmaceutical company Moderna ($MRNA) is receiving a lot of attention in Europe today, having announced earlier today that preliminary research results indicate that the potential vaccine (mRNA-1273) is 94.5% effective. This follows…

Historical Moment For Pfizer: First Late-Stage Vaccine To Be 90% Effective Against COVID-19
PFE

Covid Rapid Antigen Testing Partnership Formed – Therma Bright Is In Play – Should You Buy   Pfizer ($PFE) is the first company to release late-stage research results showing that a vaccine candidate shows a very high positive response. Pfizer and German partner BioNTech ($BNTX) now want to discuss the results with global regulatory authorities…